Hypoxia-inducible factor 1-alpha expression correlates with response to neoadjuvant chemotherapy in women with breast cancer

Hypoxia-inducible factor 1-alpha (HIF-1a) has been shown to contribute to resistance to chemotherapy in breast cancer. The purpose of this study was to investigate whether HIF-1a is predictive for pathological response and the prognostic value of HIF-1a in local advanced breast undergoing neoadjuvan...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Caiyun, Lv, Huifang, Bie, Liangyu, Hou, Honglin, Chen, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319826/
https://www.ncbi.nlm.nih.gov/pubmed/30572455
http://dx.doi.org/10.1097/MD.0000000000013551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319826/
https://www.ncbi.nlm.nih.gov/pubmed/30572455
http://dx.doi.org/10.1097/MD.0000000000013551

Ejemplares similares